Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions
Authors:
Open Access
- 6 April 2021
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 22 (1) , 1-15
Abstract
Background: COVID-19 pneumonia has been associated with severe acute hypoxia, sepsis-like states, thrombosis and chronic sequelae including persisting hypoxia and fibrosis. The molecular hypoxia response pathway has been associated with such pathologies and our recent observations on anti-hypoxic and anti-inflammatory effects of whole aqueous extract of Adhatoda Vasica (AV) prompted us to explore its effects on relevant preclinical mouse models. Methods: In this study, we tested the effect of whole aqueous extract of AV, in murine models of bleomycin induced pulmonary fibrosis, Cecum Ligation and Puncture (CLP) induced sepsis, and siRNA induced hypoxia-thrombosis phenotype. The effect on lung of AV treated naïve mice was also studied at transcriptome level. We also determined if the extract may have any effect on SARS-CoV2 replication. Results: Oral administration AV extract attenuates increased airway inflammation, levels of transforming growth factor-β1 (TGF-β1), IL-6, HIF-1α and improves the overall survival rates of mice in the models of pulmonary fibrosis and sepsis and rescues the siRNA induced inflammation and associated blood coagulation phenotypes in mice. We observed downregulation of hypoxia, inflammation, TGF-β1, and angiogenesis genes and upregulation of adaptive immunity-related genes in the lung transcriptome. AV treatment also reduced the viral load in Vero cells infected with SARS-CoV2. Conclusion: Our results provide a scientific rationale for this ayurvedic herbal medicine in ameliorating the hypoxia-hyperinflammation features and highlights the repurposing potential of AV in COVID-19-like conditions.Keywords
All Related Versions
Funding Information
- Council of Scientific and Industrial Research, India (MLP-901)
- Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (GAP-0183)
This publication has 43 references indexed in Scilit:
- MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2014
- Hypoxia Results in Upregulation and De Novo Activation of Von Willebrand Factor Expression in Lung Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Hypoxia-Induced Inflammation in the LungAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Hypoxia and InflammationNew England Journal of Medicine, 2011
- The role of interferon-γ in the pathogenesis of acute intra-abdominal sepsisJournal of Leukocyte Biology, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Hypoxia and chronic lung diseaseJournal of Molecular Medicine, 2007
- Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand ComplexesJournal of Medicinal Chemistry, 2006
- The Protein Data BankNucleic Acids Research, 2000
- A Bronchodilator Alkaloid (Vasicinone) from Adhatoda vasica NeesNature, 1959